| 1 | Patient-reported outcomes in NRG Oncology RTOG 1010: Phase 3 trial evaluating the addition of trastuzumab to trimodality treatment of HER2 overexpressing esophageal adenocarcinoma. (Kachnic LA, Moughan J, Hong TS, Haddock MG, Tahir N, Yoon HH, Diaz DA, Anderson CM, Seaward SA, Lominska CE, O'Brien PE, Chen Y, Salo JC, Christie AD, Dorth JA, Aljumaily RM, Gore EM, Winter KA, Safran HP, Movsas B) Cancer 2026 Mar 15;132(6):e70345 |
| 1 | Failure patterns and the influence of the TNM staging systems on prognosis in limited disease small cell lung Cancer (SCLC): the Turkish Oncology Group (TOG) study. (Ergen ŞA, Dinçbaş FÖ, Metcalfe E, Gül ŞK, Akyürek S, Yavaş G, Özdemir BŞ, Yücel B, Altınok A, Atalar B, Altınok P, Yakar M, Tepetam H, Birgi SD, Yavaş Ç, Korcum AF, Tatlı AM, Yumuk F) Clin Transl Oncol 2026 Apr;28(4):1234-1245 |
| 1 | Image guided brachytherapy quality assurance on NRG GY017 investigating immunotherapy in addition to chemoradiation for locally advanced cervical cancer. (Kim H, Deng W, Zamarin D, Xiao Y, Chino J, Benedict S, Nguyen H, Lowenstein J, McNulty S, Ghamande S, Ferguson C, Mell L, Holman LL, Mathews C, Quick A, Olawaiye A, Hopp E, Mannel R, Leath III CA, O'Cearbhaill RE, Aghajanian C, Schilder RJ, Mayadev J) Brachytherapy 2026;25(1):127-135 1 Citation |
| 1 | Radiogenomic Profiling of Prostate Tumors prior to External Beam Radiotherapy Converges on a Transcriptomic Signature of TGF-β Activity Driving Tumor Recurrence. (Ku AT, Shankavaram U, Trostel SY, Zhang H, Kartal S, Sater HA, Harmon SA, Carrabba NV, Liu Y, Ryu H, Proudfoot JA, Hong BH, Wood BJ, Pinto PA, Choyke PL, Roach M, Sandler HM, Pugh SL, Zeitzer KL, Mendez LC, Kapadia NS, Hall WA, Desai AB, Stoyanova RS, Pollack A, Davicioni E, Chua MLK, Turkbey B, Sowalsky AG, Citrin DE) Clin Cancer Res 2025 Dec 15;31(24):5211-5224 |
| 1 | Bayesian Counterfactual Machine Learning Individualizes Radiation Modality Selection to Mitigate Immunosuppression. (Yu D, Kane MJ, Chen Y, Lin SH, Mohan R, Hobbs BP) JCO Clin Cancer Inform 2025 Aug;9:e2500058 |
| 1 | Phase II Study of Low-Dose Paclitaxel and Cisplatin in Combination With Split-Course Concomitant Twice-Daily Reirradiation in Recurrent Squamous Cell Carcinoma of the Head and Neck: Long-term Follow-up of NRG Oncology RTOG 9911. (Langer CJ, Harris J, Horwitz EM, Kies M, Ad VB, Wong SJ, Caudell JJ, Zeitzer KL, Spencer SA, Zhang Q, Yom SS, Le QT) Int J Radiat Oncol Biol Phys 2026 Jan 01;124(1):50-60 1 Citation |
| 1 | Re-examining post-operative chemoradiotherapy in head and neck cancer: an updated long-term combined analysis of RTOG 9501/EORTC 22931. (Zumsteg ZS, Luu M, Fortpied C, Jang JK, Chen MM, Mallen-St Clair J, Walgama E, Le QT, Machtay M, Tribius S, Forastiere A, Wong S, Ozsahin EM, Gregoire V, Vermorken JB, Ho AS, Yom SS) Ann Oncol 2025 Nov;36(11):1379-1388 4 Citations |
| 1 | Transcriptomic Analysis of Localized High-risk Prostate Cancer Improves Prognostication and Identifies Benefit from Adding Docetaxel to Definitive Radiotherapy with Androgen Suppression in the NRG Oncology/RTOG 0521 Phase 3 Trial. (Phillips RM, Proudfoot JA, Davicioni E, Liu Y, Spratt DE, Simko JM, Den RB, Pollack A, Rosenthal SA, Sartor AO, Sweeney CJ, Attard G, Longoria L, Patel S, Straza MW, Efstathiou JA, Shah AB, Hoffman KE, Rodgers JP, Sandler HM, Feng FY, Tran PT) Eur Urol Oncol 2025 Aug;8(4):968-976 2 Citations |
| 1 | Evaluation of Head and Neck Squamous Cell Carcinoma (HNSCC) Patient Outcomes Based on Rurality: A Retrospective Cohort Study. (Lane S, Smith B, Brodersen C, Hanson S, Spanos W, Powell S) S D Med 2025 May;78(suppl 5):s31 |
| 1 | Comprehensive Molecular Analysis in NRG Oncology/RTOG 9813: A Phase 3 Study of Radiation and Temozolomide Versus Radiation and BCNU/CCNU in Anaplastic Astrocytoma. (Fleming JL, Pugh SL, Chang SM, McElroy JP, Becker AP, Aldape KD, Shih HA, Ashby LS, Hunter GK, Bahary JP, Schultz CJ, Kavanagh BD, Puduvalli VK, Robins HI, Werner-Wasik M, Mehta M, Chakravarti A) Int J Radiat Oncol Biol Phys 2025 Sep 01;123(1):84-92 2 Citations |
| 1 | Prognostic Impact of Low Muscle Mass and Inflammatory Markers in Stage III Nonsmall Cell Lung Cancer Turkish Oncology Group and Turkish Society of Radiation Oncology Thoracic Cancer Study Group (08-005). (Gumustepe E, Yavas G, Kirakli EK, Dincbas FÖ, N D, Hurmuz P, Koksoy EB, Catal TK, Özler T, Yilmaz Aslan MT, Akyurek S) Am J Clin Oncol 2025 Feb 01;48(2):67-74 2 Citations |
| 1 | Patient-reported outcomes (PROs) in NRG Oncology RTOG 0436: a phase III trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for esophageal cancer treated without surgery. (Kachnic LA, Winter K, Suntharalingam M, Ilson D, Konski A, Lloyd S, McAvoy SA, Lad T, Olowokure OG, Samson P, Gore EM, Meyer JE, Videtic GMM, Clump DA, Raben A, Kayaleh O, Barker J Jr, Haddock MG, Hopkins JO, Bruner DW) Qual Life Res 2024 Oct;33(10):2833-2844 2 Citations |
| 1 | Multicenter Phase 1b/2a Clinical Trial of Radioprotectant BIO 300 Oral Suspension for Patients With Non-Small Cell Lung Cancer Receiving Concurrent Chemoradiotherapy. (Simone CB 2nd, Serebrenik AA, Gore EM, Mohindra P, Brown SL, Wang D, Chetty IJ, Vujaskovic Z, Menon S, Thompson J, Fine G, Kaytor MD, Movsas B) Int J Radiat Oncol Biol Phys 2024 Feb 01;118(2):404-414 12 Citations |
| 1 | Prospective Correlation of Magnetic Resonance Tumor Regression Grade With Pathologic Outcomes in Total Neoadjuvant Therapy for Rectal Adenocarcinoma. (Hall WA, Li J, You YN, Gollub MJ, Grajo JR, Rosen M, dePrisco G, Yothers G, Dorth JA, Rahma OE, Russell MM, Gross HM, Jacobs SA, Faller BA, George S, Al Baghdadi T, Haddock MG, Valicenti R, Hong TS, George TJ) J Clin Oncol 2023 Oct 10;41(29):4643-4651 30 Citations |
| 1 | Multi-institutional analysis of cervical esophageal carcinoma patients treated with definitive chemoradiotherapy: TROD 01-005 study. (Guler OC, Oymak E, Yazici G, Akagunduz OO, Cetinayak O, Erpolat P, Aksoy A, Duzova M, Yildirim BA, Kurt M, Canyilmaz E, Yavas G, Akyurek S, Oksuz DC, Saglam EK, Celik OK, Ozyar E, Cengiz M, Onal C) Oncol Res 2023;31(3):299-306 2 Citations |
| 1 | The impact of serum albumin-to-alkaline phosphatase ratio in cervical cancer patients treated with definitive chemoradiotherapy. (Onal C, Gultekin M, Yavas G, Oymak E, Yuce Sari S, Guler OC, Yigit E, Yildiz F) J Obstet Gynaecol 2022 Aug;42(6):2426-2432 8 Citations |
| 1 | Prediction of treatment response in patients with locally advanced cervical cancer using midtreatment PET/MRI during concurrent chemoradiotherapy. In regard to Vojtíšek et al. (Onal C, Yavas G, Yavas C) Strahlenther Onkol 2021 Oct;197(10):935-936 |
| 1 | Use of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Initial Results From the Pembrolizumab Arm of a Phase 2 Randomized Clinical Trial. (Rahma OE, Yothers G, Hong TS, Russell MM, You YN, Parker W, Jacobs SA, Colangelo LH, Lucas PC, Gollub MJ, Hall WA, Kachnic LA, Vijayvergia N, O'Rourke MA, Faller BA, Valicenti RK, Schefter TE, George S, Kainthla R, Stella PJ, Sigurdson E, Wolmark N, George TJ) JAMA Oncol 2021 Aug 01;7(8):1225-1230 187 Citations |
| 1 | Pediatric classical Hodgkin lymphoma. (Lo AC, Dieckmann K, Pelz T, Gallop-Evans E, Engenhart-Cabillic R, Vordermark D, Kelly KM, Schwartz CL, Constine LS, Roberts K, Hodgson D) Pediatr Blood Cancer 2021 May;68 Suppl 2:e28562 30 Citations |
| 1 | The impact of age on outcome in phase III NRG Oncology/RTOG trials of radiotherapy (XRT) +/- systemic therapy in locally advanced head and neck cancer. (Kish JA, Zhang Q, Langer CJ, Nguyen-Tân PF, Rosenthal DI, Weber RS, List MA, Wong SJ, Garden AS, Hu K, Trotti AM, Bonner JA, Jones CU, Yom SS, Thorstad W, Schultz CJ, Ridge JA, Shenouda G, Harris J, Le QT) J Geriatr Oncol 2021 Jul;12(6):937-944 8 Citations |
| 1 | Risk groups of laryngeal cancer treated with chemoradiation according to nomogram scores - A pooled analysis of RTOG 0129 and 0522. (Awan MJ, Gittleman H, Barnholtz-Sloan J, Machtay M, Nguyen-Tan PF, Rosenthal DI, Schultz C, Huth BJ, Thorstad WL, Frank SJ, Kim H, Foote RL, Lango MN, Shenouda G, Suntharalingam M, Harris J, Zhang Q, Le QT, Yao M, NRG Oncology Group) Oral Oncol 2021 May;116:105241 5 Citations |
| 1 | High prevalence of clonal hematopoiesis-type genomic abnormalities in cell-free DNA in invasive gliomas after treatment. (Okamura R, Piccioni DE, Boichard A, Lee S, Jimenez RE, Sicklick JK, Kato S, Kurzrock R) Int J Cancer 2021 Jun 01;148(11):2839-2847 32 Citations |
| 2 | Post-transplant primary cutaneous peripheral T-cell lymphoma not otherwise specified in a pediatric patient. (Cardwell LA, Majerowski J, Chiu YE, Harrington AM, Sokumbi O) J Cutan Pathol 2021 May;48(5):706-712 4 Citations |
| 1 | A stem cell reporter based platform to identify and target drug resistant stem cells in myeloid leukemia. (Spinler K, Bajaj J, Ito T, Zimdahl B, Hamilton M, Ahmadi A, Koechlein CS, Lytle N, Kwon HY, Anower-E-Khuda F, Sun H, Blevins A, Weeks J, Kritzik M, Karlseder J, Ginsberg MH, Park PW, Esko JD, Reya T) Nat Commun 2020 Nov 26;11(1):5998 13 Citations |
| 7 | Radiographic patterns of first disease recurrence after neoadjuvant therapy and surgery for patients with resectable and borderline resectable pancreatic cancer. (Barnes CA, Aldakkak M, Christians KK, Clarke CN, Dua K, George B, Ritch PS, Kamgar M, Hall WA, Kulkarni N, Erickson BA, Evans DB, Tsai S) Surgery 2020 Sep;168(3):440-447 16 Citations |
| 3 | Pulsed Reduced Dose Rate Radiotherapy in Conjunction With Bevacizumab or Bevacizumab Alone in Recurrent High-grade Glioma: Survival Outcomes. (Bovi JA, Prah MA, Retzlaff AA, Schmainda KM, Connelly JM, Rand SD, Marszalkowski CS, Mueller WM, Siker ML, Schultz CJ) Int J Radiat Oncol Biol Phys 2020 Nov 15;108(4):979-986 25 Citations |
| 1 | Modeling the Impact of Cardiopulmonary Irradiation on Overall Survival in NRG Oncology Trial RTOG 0617. (Thor M, Deasy JO, Hu C, Gore E, Bar-Ad V, Robinson C, Wheatley M, Oh JH, Bogart J, Garces YI, Kavadi VS, Narayan S, Iyengar P, Witt JS, Welsh JW, Koprowski CD, Larner JM, Xiao Y, Bradley J) Clin Cancer Res 2020 Sep 01;26(17):4643-4650 67 Citations |
| 1 | High dose radiation therapy based on normal tissue constraints with concurrent chemotherapy achieves promising survival of patients with unresectable stage III non-small cell lung cancer. (Zhao Q, Liu M, Wang Z, Huang W, Allen Li X, Zhou T, Zhang J, Zhang Z, Wang Q, Yu S, Han D, Sun H, Li H, Lin H, Li B) Radiother Oncol 2020 Apr;145:7-12 4 Citations |
| 1 | Correlation of CT texture changes with treatment response during radiation therapy for esophageal cancer: An exploratory study. (Yan Z, Zhang J, Long H, Sun X, Li D, Tang T, Li XA, Hui W) PLoS One 2019;14(9):e0223140 8 Citations |
| 2 | Contemporary Outcomes for Advanced-Stage Classical Hodgkin Lymphoma in the U.S.: Analysis of Surveillance, Epidemiology, and End Results Database. (Guru Murthy GS, Szabo A, Hamadani M, Fenske TS, Shah NN) Oncologist 2019 Nov;24(11):1488-1495 11 Citations |
| 1 | Nomogram to Predict the Benefit of Intensive Treatment for Locoregionally Advanced Head and Neck Cancer. (Mell LK, Shen H, Nguyen-Tân PF, Rosenthal DI, Zakeri K, Vitzthum LK, Frank SJ, Schiff PB, Trotti AM 3rd, Bonner JA, Jones CU, Yom SS, Thorstad WL, Wong SJ, Shenouda G, Ridge JA, Zhang QE, Le QT) Clin Cancer Res 2019 Dec 01;25(23):7078-7088 25 Citations |
| 1 | Comment on De Felice et al, "Intensified Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer in Elderly Patients: Toxicity, Disease Control, and Survival Outcomes". (Yavas G, Yavas C) Clin Colorectal Cancer 2019 Dec;18(4):e368-e369 1 Citation |
| 1 | Validation of NRG oncology/RTOG-0129 risk groups for HPV-positive and HPV-negative oropharyngeal squamous cell cancer: Implications for risk-based therapeutic intensity trials. (Fakhry C, Zhang Q, Gillison ML, Nguyen-Tân PF, Rosenthal DI, Weber RS, Lambert L, Trotti AM 3rd, Barrett WL, Thorstad WL, Yom SS, Wong SJ, Ridge JA, Rao SSD, Spencer S, Fortin A, Raben D, Harris J, Le QT) Cancer 2019 Jun 15;125(12):2027-2038 69 Citations |
| 1 | Dose-volume relationship for laryngeal substructures and aspiration in patients with locally advanced head-and-neck cancer. (Petras KG, Rademaker AW, Refaat T, Choi M, Thomas TO, Pauloski BR, Mittal BB) Radiat Oncol 2019 Mar 18;14(1):49 11 Citations |
| 1 | Pathologic necrosis following neoadjuvant radiotherapy or chemoradiotherapy is prognostic of poor survival in soft tissue sarcoma. (Gannon NP, Stemm MH, King DM, Bedi M) J Cancer Res Clin Oncol 2019 May;145(5):1321-1330 31 Citations |
| 1 | Time stability of delta-radiomics features and the impact on patient analysis in longitudinal CT images. (Plautz TE, Zheng C, Noid G, Li XA) Med Phys 2019 Apr;46(4):1663-1676 19 Citations |
| 1 | Adjuvant carboplatin and paclitaxel after concurrent cisplatin and radiotherapy in patients with locally advanced cervical cancer. (Yavas G, Yavas C, Sen E, Oner I, Celik C, Ata O) Int J Gynecol Cancer 2019 Jan;29(1):42-47 31 Citations |
| 2 | Patient selection in studies evaluating esophageal stents during neoadjuvant therapy. (Smith ZL, Dua KS) Gastrointest Endosc 2019 Jan;89(1):205-206 2 Citations |
| 2 | Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial. (Roach M, Moughan J, Lawton CAF, Dicker AP, Zeitzer KL, Gore EM, Kwok Y, Seider MJ, Hsu IC, Hartford AC, Horwitz EM, Yamoah K, Jones CU, Michalski JM, Lee WR, Pisansky TM, Rabinovitch R, Rotman M, Pryzant RM, Kim HE, Thomas CR Jr, Shipley WU, Sandler HM) Lancet Oncol 2018 Nov;19(11):1504-1515 214 Citations |
| 1 | Outcomes in intermediate-risk pediatric lymphocyte-predominant Hodgkin lymphoma: A report from the Children's Oncology Group. (Marks LJ, Pei Q, Bush R, Buxton A, Appel B, Kelly KM, Schwartz CL, Friedman DL) Pediatr Blood Cancer 2018 Dec;65(12):e27375 11 Citations |
| 1 | Pericardial effusion in Hodgkin lymphoma: a report from the Children's Oncology Group AHOD0031 protocol. (Marks LJ, McCarten KM, Pei Q, Friedman DL, Schwartz CL, Kelly KM) Blood 2018 Sep 13;132(11):1208-1211 14 Citations |
| 1 | Effect of Primary Tumor Side on Survival Outcomes in Untreated Patients With Metastatic Colorectal Cancer When Selective Internal Radiation Therapy Is Added to Chemotherapy: Combined Analysis of Two Randomized Controlled Studies. (Gibbs P, Heinemann V, Sharma NK, Taieb J, Ricke J, Peeters M, Findlay M, Robinson B, Jackson C, Strickland A, Gebski V, Van Buskirk M, Zhao H, van Hazel G, SIRFLOX and FOXFIRE Global Trial Investigators) Clin Colorectal Cancer 2018 Dec;17(4):e617-e629 64 Citations |
| 1 | Association of MGMT Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide: An Analysis From the NRG Oncology/RTOG 0424 Trial. (Bell EH, Zhang P, Fisher BJ, Macdonald DR, McElroy JP, Lesser GJ, Fleming J, Chakraborty AR, Liu Z, Becker AP, Fabian D, Aldape KD, Ashby LS, Werner-Wasik M, Walker EM, Bahary JP, Kwok Y, Yu HM, Laack NN, Schultz CJ, Gray HJ, Robins HI, Mehta MP, Chakravarti A) JAMA Oncol 2018 Oct 01;4(10):1405-1409 153 Citations |
| 1 | Quantifying local tumor morphological changes with Jacobian map for prediction of pathologic tumor response to chemo-radiotherapy in locally advanced esophageal cancer. (Riyahi S, Choi W, Liu CJ, Zhong H, Wu AJ, Mechalakos JG, Lu W) Phys Med Biol 2018 Jul 19;63(14):145020 36 Citations |
| 2 | Final results of a multi-institutional phase II trial of reirradiation with concurrent weekly cisplatin and cetuximab for recurrent or second primary squamous cell carcinoma of the head and neck. (Awan MJ, Nedzi L, Wang D, Tumati V, Sumer B, Xie XJ, Smith I, Truelson J, Hughes R, Myers LL, Lavertu P, Wong S, Yao M) Ann Oncol 2018 Apr 01;29(4):998-1003 22 Citations |
| 1 | Soft palate reconstruction after radionecrosis: Combined anterolateral thigh adipofascial and nasoseptal flaps. (Zenga J, Sharon JD, Gross J, Gantz J, Pipkorn P) Auris Nasus Larynx 2018 Aug;45(4):875-879 6 Citations |
| 1 | Comment on "Serum human epididymis protein 4 is associated with the treatment response of concurrent chemo-radiotherapy and prognosis in patients with locally advanced non-small cell lung cancer" by Lan WG et al. (Yavas G, Yavas C, Akyurek S) Clin Transl Oncol 2018 Jun;20(6):801-802 |
| 1 | Trials in head and neck oncology: Evolution of perioperative adjuvant therapy. (Zenga J, Pipkorn P, Adkins DR, Thorstad WL, Nussenbaum B) Oral Oncol 2017 Sep;72:80-89 4 Citations |
| 1 | Development and Validation of Nomograms Predictive of Overall and Progression-Free Survival in Patients With Oropharyngeal Cancer. (Fakhry C, Zhang Q, Nguyen-Tân PF, Rosenthal DI, Weber RS, Lambert L, Trotti AM 3rd, Barrett WL, Thorstad WL, Jones CU, Yom SS, Wong SJ, Ridge JA, Rao SSD, Bonner JA, Vigneault E, Raben D, Kudrimoti MR, Harris J, Le QT, Gillison ML) J Clin Oncol 2017 Dec 20;35(36):4057-4065 130 Citations |
| 3 | Assessment of treatment response during chemoradiation therapy for pancreatic cancer based on quantitative radiomic analysis of daily CTs: An exploratory study. (Chen X, Oshima K, Schott D, Wu H, Hall W, Song Y, Tao Y, Li D, Zheng C, Knechtges P, Erickson B, Li XA) PLoS One 2017;12(6):e0178961 81 Citations |
| 1 | American Brachytherapy Task Group Report: A pooled analysis of clinical outcomes for high-dose-rate brachytherapy for cervical cancer. (Mayadev J, Viswanathan A, Liu Y, Li CS, Albuquerque K, Damato AL, Beriwal S, Erickson B) Brachytherapy 2017;16(1):22-43 39 Citations |
| 1 | Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813. (Chang S, Zhang P, Cairncross JG, Gilbert MR, Bahary JP, Dolinskas CA, Chakravarti A, Aldape KD, Bell EH, Schiff D, Jaeckle K, Brown PD, Barger GR, Werner-Wasik M, Shih H, Brachman D, Penas-Prado M, Robins HI, Belanger K, Schultz C, Hunter G, Mehta M) Neuro Oncol 2017 Feb 01;19(2):252-258 80 Citations |
| 1 | Intravoxel incoherent motion diffusion-weighted MRI during chemoradiation therapy to characterize and monitor treatment response in human papillomavirus head and neck squamous cell carcinoma. (Paudyal R, Oh JH, Riaz N, Venigalla P, Li J, Hatzoglou V, Leeman J, Nunez DA, Lu Y, Deasy JO, Lee N, Shukla-Dave A) J Magn Reson Imaging 2017 Apr;45(4):1013-1023 59 Citations |
| 1 | Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Experience. (Cloyd JM, Katz MH, Prakash L, Varadhachary GR, Wolff RA, Shroff RT, Javle M, Fogelman D, Overman M, Crane CH, Koay EJ, Das P, Krishnan S, Minsky BD, Lee JH, Bhutani MS, Weston B, Ross W, Bhosale P, Tamm EP, Wang H, Maitra A, Kim MP, Aloia TA, Vauthey JN, Fleming JB, Abbruzzese JL, Pisters PW, Evans DB, Lee JE) J Gastrointest Surg 2017 Jan;21(1):164-174 128 Citations |
| 1 | Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Standard Radiation Versus Accelerated Radiation Plus Cisplatin for Locally Advanced Head and Neck Carcinoma: NRG Oncology RTOG 0129. (Xiao C, Zhang Q, Nguyen-Tân PF, List M, Weber RS, Ang KK, Rosenthal D, Filion EJ, Kim H, Silverman C, Raben A, Galloway T, Fortin A, Gore E, Winquist E, Jones CU, Robinson W, Raben D, Le QT, Bruner D) Int J Radiat Oncol Biol Phys 2017 Mar 15;97(4):667-677 35 Citations |
| 1 | The management of patients with esophageal cancer and coronary artery stenosis undergoing radiotherapy or concurrent chemoradiotherapy: a single-center experience. (Luo H, Chen X, Zhang Q, Wang L, Qiao L, Liang N, Xie J, Yu X, Song M, Liu Z, Lv Y, Liu F, Tian Y, Cheng J, Deng G, Zhang J, Li XA, Zhang J) J BUON 2016;21(2):419-26 1 Citation |
| 6 | Mitochondria-Targeted Analogues of Metformin Exhibit Enhanced Antiproliferative and Radiosensitizing Effects in Pancreatic Cancer Cells. (Cheng G, Zielonka J, Ouari O, Lopez M, McAllister D, Boyle K, Barrios CS, Weber JJ, Johnson BD, Hardy M, Dwinell MB, Kalyanaraman B) Cancer Res 2016 Jul 01;76(13):3904-15 181 Citations |
| 1 | Phase I and II Study of Induction Chemotherapy With Methotrexate, Rituximab, and Temozolomide, Followed By Whole-Brain Radiotherapy and Postirradiation Temozolomide for Primary CNS Lymphoma: NRG Oncology RTOG 0227. (Glass J, Won M, Schultz CJ, Brat D, Bartlett NL, Suh JH, Werner-Wasik M, Fisher BJ, Liepman MK, Augspurger M, Bokstein F, Bovi JA, Solhjem MC, Mehta MP) J Clin Oncol 2016 May 10;34(14):1620-5 124 Citations |
| 1 | ACR Appropriateness Criteria Radiologic Management of Hepatic Malignancy. (Kouri BE, Abrams RA, Al-Refaie WB, Azad N, Farrell J, Gaba RC, Gervais DA, Gipson MG, Kolbeck KJ, Marshalleck FE, Pinchot JW, Small W Jr, Ray CE Jr, Hohenwalter EJ) J Am Coll Radiol 2016 Mar;13(3):265-73 11 Citations |
| 1 | Metastatic Cancer to the Larynx: A Case Report and Update. (Zenga J, Mehrad M, Bradley JP) J Voice 2016 Nov;30(6):774.e9-774.e12 13 Citations |
| 5 | Survival of patients with resectable pancreatic cancer who received neoadjuvant therapy. (Christians KK, Heimler JW, George B, Ritch PS, Erickson BA, Johnston F, Tolat PP, Foley WD, Evans DB, Tsai S) Surgery 2016 Mar;159(3):893-900 107 Citations |
| 1 | Hyoid osteoradionecrosis accompanied by candida infection. (Yavaş G, Kara Gedik G, Çolpan B, Ata Ö, Öztürk K, Sarı O) Kulak Burun Bogaz Ihtis Derg 2015;25(5):310-4 3 Citations |
| 1 | Definitive radiation therapy in locally advanced non-small cell lung cancer: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based clinical practice guideline. (Rodrigues G, Choy H, Bradley J, Rosenzweig KE, Bogart J, Curran WJ Jr, Gore E, Langer C, Louie AV, Lutz S, Machtay M, Puri V, Werner-Wasik M, Videtic GMM) Pract Radiat Oncol 2015;5(3):141-148 81 Citations |
| 1 | Duration of androgen suppression before radiotherapy for localized prostate cancer: radiation therapy oncology group randomized clinical trial 9910. (Pisansky TM, Hunt D, Gomella LG, Amin MB, Balogh AG, Chinn DM, Seider MJ, Duclos M, Rosenthal SA, Bauman GS, Gore EM, Rotman MZ, Lukka HR, Shipley WU, Dignam JJ, Sandler HM) J Clin Oncol 2015 Feb 01;33(4):332-9 120 Citations |
| 1 | Characterization of Anthropometric Changes that Occur During Neoadjuvant Therapy for Potentially Resectable Pancreatic Cancer. (Cooper AB, Slack R, Fogelman D, Holmes HM, Petzel M, Parker N, Balachandran A, Garg N, Ngo-Huang A, Varadhachary G, Evans DB, Lee JE, Aloia T, Conrad C, Vauthey JN, Fleming JB, Katz MH) Ann Surg Oncol 2015 Jul;22(7):2416-23 139 Citations |
| 1 | Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer: the SIRFLOX study. (Gibbs P, Gebski V, Van Buskirk M, Thurston K, Cade DN, Van Hazel GA, SIRFLOX Study Group) BMC Cancer 2014 Dec 01;14:897 55 Citations |
| 2 | Efficacy endpoints of radiation therapy group protocol 0247: a randomized, phase 2 study of neoadjuvant radiation therapy plus concurrent capecitabine and irinotecan or capecitabine and oxaliplatin for patients with locally advanced rectal cancer. (Wong SJ, Moughan J, Meropol NJ, Anne PR, Kachnic LA, Rashid A, Watson JC, Mitchell EP, Pollock J, Lee RJ, Haddock M, Erickson BA, Willett CG) Int J Radiat Oncol Biol Phys 2015 Jan 01;91(1):116-23 34 Citations |
| 4 | Cisplatin and etoposide versus carboplatin and paclitaxel with concurrent radiotherapy for stage III non-small-cell lung cancer: an analysis of Veterans Health Administration data. (Santana-Davila R, Devisetty K, Szabo A, Sparapani R, Arce-Lara C, Gore EM, Moran A, Williams CD, Kelley MJ, Whittle J) J Clin Oncol 2015 Feb 20;33(6):567-74 120 Citations |
| 1 | Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity. (Nguyen-Tan PF, Zhang Q, Ang KK, Weber RS, Rosenthal DI, Soulieres D, Kim H, Silverman C, Raben A, Galloway TJ, Fortin A, Gore E, Westra WH, Chung CH, Jordan RC, Gillison ML, List M, Le QT) J Clin Oncol 2014 Dec 01;32(34):3858-66 418 Citations |
| 3 | Radiation dose responses for chemoradiation therapy of pancreatic cancer: an analysis of compiled clinical data using biophysical models. (Moraru IC, Tai A, Erickson B, Li XA) Pract Radiat Oncol 2014;4(1):13-9 39 Citations |
| 1 | Acr appropriateness Criteria management of vaginal cancer. (Lee LJ, Jhingran A, Kidd E, Cardenes HR, Elshaikh MA, Erickson B, Mayr NA, Moore D, Puthawala AA, Rao GG, Small W Jr, Varia MA, Wahl AO, Wolfson AH, Yashar CM, Yuh W, Gaffney DK) Oncology (Williston Park) 2013 Nov;27(11):1166-73 22 Citations |
| 1 | Chemoradiation therapy sequencing for resected pancreatic adenocarcinoma in the National Cancer Data Base. (Colbert LE, Hall WA, Nickleach D, Switchenko J, Kooby DA, Liu Y, Gillespie T, Lipscomb J, Kauh J, Landry JC) Cancer 2014 Feb 15;120(4):499-506 40 Citations |
| 1 | Neutrophil:lymphocyte ratio as a simple and novel biomarker for prediction of locoregional recurrence after chemoradiotherapy for squamous cell carcinoma of the anus. (Toh E, Wilson J, Sebag-Montefiore D, Botterill I) Colorectal Dis 2014 Mar;16(3):O90-7 34 Citations |
| 1 | Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial. (Gilbert MR, Wang M, Aldape KD, Stupp R, Hegi ME, Jaeckle KA, Armstrong TS, Wefel JS, Won M, Blumenthal DT, Mahajan A, Schultz CJ, Erridge S, Baumert B, Hopkins KI, Tzuk-Shina T, Brown PD, Chakravarti A, Curran WJ Jr, Mehta MP) J Clin Oncol 2013 Nov 10;31(32):4085-91 913 Citations |
| 1 | Incidence of pineal gland cyst and pineoblastoma in children with retinoblastoma during the chemoreduction era. (Ramasubramanian A, Kytasty C, Meadows AT, Shields JA, Leahey A, Shields CL) Am J Ophthalmol 2013 Oct;156(4):825-9 39 Citations |
| 1 | ACR Appropriateness Criteria® management of locoregionally advanced squamous cell carcinoma of the vulva. (Expert Panel on Radiation Oncology-Gynecology, Kidd E, Moore D, Varia MA, Gaffney DK, Elshaikh MA, Erickson B, Jhingran A, Lee LJ, Mayr NA, Puthawala AA, Rao GG, Small W Jr, Wahl AO, Wolfson AH, Yashar CM, Yuh W, Cardenes HR) Am J Clin Oncol 2013 Aug;36(4):415-22 18 Citations |
| 4 | Prognostic variables in patients with primary soft tissue sarcoma of the extremity and trunk treated with neoadjuvant radiotherapy or neoadjuvant sequential chemoradiotherapy. (Bedi M, King DM, Shivakoti M, Wang T, Zambrano EV, Charlson J, Hackbarth D, Neilson J, Whitfield R, Wang D) Radiat Oncol 2013 Mar 14;8:60 24 Citations |
| 1 | The cost-effectiveness of neoadjuvant chemoradiation is superior to a surgery-first approach in the treatment of pancreatic head adenocarcinoma. (Abbott DE, Tzeng CW, Merkow RP, Cantor SB, Chang GJ, Katz MH, Bentrem DJ, Bilimoria KY, Crane CH, Varadhachary GR, Abbruzzese JL, Wolff RA, Lee JE, Evans DB, Fleming JB) Ann Surg Oncol 2013 Dec;20 Suppl 3:S500-8 62 Citations |
| 1 | Five-year outcomes of squamous cell carcinoma of the tonsil treated with radiotherapy. (Mourad WF, Hu KS, Puckett L, Hauerstock D, Shourbaji RA, Li Z, Manolidis S, Schantz S, Tran T, Jacobson A, Urken M, Culliney B, Persky M, Harrison LB) Am J Clin Oncol 2014 Feb;37(1):57-62 6 Citations |
| 1 | Recent advances in systemic therapies and radiotherapy for gallbladder cancer. (Caldow Pilgrim CH, Groeschl RT, Quebbeman EJ, Gamblin TC) Surg Oncol 2013 Mar;22(1):61-7 33 Citations |
| 1 | Penetration of recommended procedures for lung cancer staging and management in the United States over 10 years: a quality research in radiation oncology survey. (Komaki R, Khalid N, Langer CJ, Kong FM, Owen JB, Crozier CL, Wilson JF, Wei X, Movsas B) Int J Radiat Oncol Biol Phys 2013 Mar 15;85(4):1082-9 52 Citations |
| 1 | Neosquamous epithelium after ablation of Barrett's epithelium: cause for concern? (Dua KS, Merrill J, Komorowski R) Gastrointest Endosc 2012 Nov;76(5):1082-3 2 Citations |
| 1 | Retreatment of recurrent head and neck cancer in a previously irradiated field. (Wong SJ, Bourhis J, Langer CJ) Semin Radiat Oncol 2012 Jul;22(3):214-9 14 Citations |
| 1 | Long-term outcomes after autologous stem cell transplantation for patients with POEMS syndrome (osteosclerotic myeloma): a single-center experience. (D'Souza A, Lacy M, Gertz M, Kumar S, Buadi F, Hayman S, Dingli D, Zeldenrust S, Kyle R, Ansell S, Inwards D, Johnston P, Micallef I, Porrata L, Litzow M, Gastineau D, Hogan W, Dispenzieri A) Blood 2012 Jul 05;120(1):56-62 150 Citations |
| 1 | Head and neck carcinoma in the United States: first comprehensive report of the Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN). (Ang KK, Chen A, Curran WJ Jr, Garden AS, Harari PM, Murphy BA, Wong SJ, Bellm LA, Schwartz M, Newman J, Adkins D, Hayes DN, Parvathaneni U, Brachman D, Ghabach B, Schneider CJ, Greenberg M, Anné PR) Cancer 2012 Dec 01;118(23):5783-92 58 Citations |
| 1 | The quality of cervical cancer brachytherapy implantation and the impact on local recurrence and disease-free survival in radiation therapy oncology group prospective trials 0116 and 0128. (Viswanathan AN, Moughan J, Small W Jr, Levenback C, Iyer R, Hymes S, Dicker AP, Miller B, Erickson B, Gaffney DK) Int J Gynecol Cancer 2012 Jan;22(1):123-31 122 Citations |
| 1 | Histologic tumor involvement of superior mesenteric vein/portal vein predicts poor prognosis in patients with stage II pancreatic adenocarcinoma treated with neoadjuvant chemoradiation. (Wang J, Estrella JS, Peng L, Rashid A, Varadhachary GR, Wang H, Lee JE, Pisters PW, Vauthey JN, Katz MH, Gomez HF, Evans DB, Abbruzzese JL, Fleming JB, Wang H) Cancer 2012 Aug 01;118(15):3801-11 60 Citations |
| 3 | Continuous-course reirradiation with concurrent carboplatin and paclitaxel for locally recurrent, nonmetastatic squamous cell carcinoma of the head-and-neck. (Kharofa J, Choong N, Wang D, Firat S, Schultz C, Sadasiwan C, Wong S) Int J Radiat Oncol Biol Phys 2012 Jun 01;83(2):690-5 40 Citations |
| 2 | Radiation Therapy Oncology Group 0247: a randomized Phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancer. (Wong SJ, Winter K, Meropol NJ, Anne PR, Kachnic L, Rashid A, Watson JC, Mitchell E, Pollock J, Lee RJ, Haddock M, Erickson BA, Willett CG) Int J Radiat Oncol Biol Phys 2012 Mar 15;82(4):1367-75 74 Citations |
| 9 | Comparison of physical examination and fluorodeoxyglucose positron emission tomography/computed tomography 4-6 months after radiotherapy to assess residual head-and-neck cancer. (Zundel MT, Michel MA, Schultz CJ, Maheshwari M, Wong SJ, Campbell BH, Massey BL, Blumin J, Wilson JF, Wang D) Int J Radiat Oncol Biol Phys 2011 Dec 01;81(5):e825-32 37 Citations |
| 1 | ACR Appropriateness Criteria® on Advanced Cervical Cancer Expert Panel on Radiation Oncology-Gynecology. (Gaffney DK, Erickson-Wittmann BA, Jhingran A, Mayr NA, Puthawala AA, Moore D, Rao GG, Small W Jr, Varia MA, Wolfson AH, Yashar CM, Yuh W, Cardenes HR) Int J Radiat Oncol Biol Phys 2011 Nov 01;81(3):609-14 71 Citations |
| 1 | Higher biologically effective dose of radiotherapy is associated with improved outcomes for locally advanced non-small cell lung carcinoma treated with chemoradiation: an analysis of the Radiation Therapy Oncology Group. (Machtay M, Bae K, Movsas B, Paulus R, Gore EM, Komaki R, Albain K, Sause WT, Curran WJ) Int J Radiat Oncol Biol Phys 2012 Jan 01;82(1):425-34 267 Citations |
